International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7976392
Original Article
Study of Thyroid Dysfunction in Type 2 Diabetes Mellitus Patients in Kr Hospital, Mysore
 ,
Published
May 27, 2023
Abstract
Background: Diabetes mellitus and thyroid dysfunction are two common endocrine disorders. The unrecognized subclinical Thyroid dysfunction may adversely affect metabolic control and increase cardiovascular risk. Our aim was to investigate the prevalence and patterns of Thyroid dysfunction in patients with type 2 diabetes mellitus in an observational cross-sectional study. Screening for thyroid dysfunction in diabetic patients will allow early treatment of hypothyroidism. Thyroid hormones and insulin both are involved in cellular metabolism antagonistically. Therefore, excess or deficit of any one of them may result in metabolic derangement. Recently, interest has been raised for the influence of thyroid hormone action on insulin levels. Conflicting data are available on influence of insulin levels on thyroid dysfunction. The development of IR may also lead to many metabolic abnormalities. Objective: Study of thyroid dysfunction in type 2 diabetes mellitus. Methods: Data was collected from the Type 2 Diabetes mellitus patients who visited the OPD or got admitted at KR Hospital, Mysore medical college, Mysore. The necessary blood tests, urine examination and imaging were done as per the proforma. Results: In our study,16 out 100 patients had abnormal thyroid profile.7 patients have overt hypothyroidism,5 patients have subclinical hypothyroidism,3 have hyperthyroidism and 1 has subclinical hyperthyroidism. Our study has high Prevalence of Thyroid dysfunction in females among type 2 diabetes mellitus. Conclusion: This study showed high prevalence of thyroid dysfunctions in patients of type 2 diabetes mellitus. Hence, we conclude that screening for thyroid dysfunction among patients with diabetes mellitus should be routinely performed, so as to recognize these dysfunctions early
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2961 Views
84 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved